Before first use
Store refrigerated at 2–8°C. Do not freeze.
Online assessment, prescribing when suitable and follow-up through every stage of dose adjustment.
The doctor reviews BMI, weight-related conditions, current medicines, previous GLP-1 treatment, pregnancy plans and contraindications.
Treatment commonly starts at 2.5 mg once weekly, with later stages of 5, 7.5, 10, 12.5 and 15 mg where appropriate.
Always follow your individual prescription and current official leaflet.
Digestive side effects are common, particularly around dose changes. The doctor reviews tolerance, hydration and weight change before deciding whether to increase.
Store refrigerated at 2–8°C. Do not freeze.
KwikPen may be kept below 30°C and should be discarded 30 days after first use.
Take within 4 days. After more than 4 days, skip it and resume on the usual day.
Do not double dose; the minimum time between doses is at least 3 days.
Current EMA Mounjaro product information. Your prescription and clinician’s advice take priority.
Registered clinicians review eligibility, prescribing, side effects and dose progression.
Meet the team →Assessment can be remote, but prescription is issued only after suitability is confirmed.
Mounjaro is injected once weekly on the prescribed dose.
Current EMA information states 30 days after first use below 30°C.
The doctor must review dose, timing, reason and tolerability.
Not automatically. It depends on response and side effects.
The doctor can discuss ongoing monitoring and prescription interval.
Take within 4 days; after that, skip and resume on the usual day.
Use original packaging and plan safe temperature control.